class="wp-theme-Newspaper supp-body td-standard-pack global-block-template-1 tdc-header-template tdc-footer-template td-animation-stack-type0 td-full-layout"
Poor bioavailability limits efficacy. No significant drug interactions documented. Generally safe.
Flavone that inhibits aromatase in vitro. Used for testosterone support. Oral bioavailability very poor.
Inhibits 5-alpha-reductase converting testosterone to DHT or acts as competitive DHT-androgen receptor antagonist. May modulate LH receptor signalling to support testosterone production. Anti-oestrogenic effects possible via aromatase inhibition.
| Population | Safety rating | Max safe dose |
|---|---|---|
| General | Possibly safe | No established UL |
| Very poor bioavailability. No significant drug interactions. | ||
No peer-reviewed clinical trial data found for this ingredient.
Data by supplement.ge — Public Health Institute of Georgia (PHIG)